![NBY - Novabay Pharmaceuticals Inc - Stock Price Chart](https://charts2-node.finviz.com/chart.ashx?cs=l&t=NBY&tf=d&s=linear&ct=candle_stick&tm=d&o[0][ot]=sma&o[0][op]=50&o[0][oc]=FF8F33C6&o[1][ot]=sma&o[1][op]=200&o[1][oc]=DCB3326D&o[2][ot]=sma&o[2][op]=20&o[2][oc]=DC32B363&o[3][ot]=patterns&o[3][op]=&o[3][oc]=000) |
Market Cap | 0.95M | EPS (ttm) | -91.04 |
P/E | - | EPS this Y | 95.71% |
Forward P/E | - | EPS next Y | 94.12% |
PEG | - | EPS past 5Y | 24.47% |
P/S | 0.07 | EPS next 5Y | - |
P/B | - | EPS Q/Q | 83.54% |
Dividend | - | Sales Q/Q | -15.78% |
Insider Own | 0.02% | Inst Own | 0.92% |
Insider Trans | 0.00% | Inst Trans | 174.50% |
Short Float | 7.03% | Earnings | May 09/a |
Analyst Recom | 1.00 | Target Price | 58.62 |
Avg Volume | 317.17K | 52W Range | 1.85 - 44.80 |
|
|
|
NovaBay Pharmaceuticals, Inc. engages in the development and sales of scientifically-created and clinically-proven eyecare and skincare. Its products include Avenova, NeutroPhase, CelleRx, and DERMAdoctor. The company was founded on January 19, 2000 and is headquartered in Emeryville, CA. |
|
![](gfx/nic2x2.gif) |
![DXCM - Dexcom Inc - Stock Price Chart](https://charts2-node.finviz.com/chart.ashx?cs=l&t=DXCM&tf=d&s=linear&ct=candle_stick&tm=d&o[0][ot]=sma&o[0][op]=50&o[0][oc]=FF8F33C6&o[1][ot]=sma&o[1][op]=200&o[1][oc]=DCB3326D&o[2][ot]=sma&o[2][op]=20&o[2][oc]=DC32B363&o[3][ot]=patterns&o[3][op]=&o[3][oc]=000) |
Market Cap | 25.45B | EPS (ttm) | 1.62 |
P/E | 39.44 | EPS this Y | 11.96% |
Forward P/E | 31.65 | EPS next Y | 18.83% |
PEG | 2.18 | EPS past 5Y | - |
P/S | 6.47 | EPS next 5Y | 18.05% |
P/B | 10.53 | EPS Q/Q | 26.60% |
Dividend | - | Sales Q/Q | 15.26% |
Insider Own | 1.55% | Inst Own | 94.12% |
Insider Trans | -3.55% | Inst Trans | -0.34% |
Short Float | 2.66% | Earnings | Jul 25/a |
Analyst Recom | 1.63 | Target Price | 102.90 |
Avg Volume | 2.85M | 52W Range | 74.75 - 142.00 |
|
|
Today | Downgrade |
JP Morgan |
Overweight → Neutral |
$145 → $75 |
Today | Downgrade |
Robert W. Baird |
Outperform → Neutral |
$161 → $80 |
|
Today 06:33PM
|
Dexcom stock plummeting is an 'opportunity to add to positions', says Wolfe Research's Mike Polark
(CNBC TV) -40.66% |
05:12PM
|
S&P 500 Gains and Losses Today: 3M Stock Skyrockets After Beat-and-Raise Report
(Investopedia) |
04:17PM
|
Dexcom Stock Crashes 41% After Slashing Its Guidance On A 'Painfully Self-Inflicted' Quarter
(Investor's Business Daily) |
04:16PM
|
These Stocks Moved the Most Today: DexCom, 3M, Nvidia, Bristol Myers, Coursera, Biogen, Charter, Deckers, and More
(Barrons.com) |
04:07PM
|
Are GLP-1 drugs creating headwinds for medical device makers?
(Yahoo Finance Video) |
03:17PM
|
Midday movers: NVIDIA, Meta, Microsoft up, diabetes stock slumps
(TheStreet) |
02:23PM
|
These Stocks Are Moving the Most Today: DexCom, 3M, Nvidia, Bristol Myers, Coursera, Biogen, Charter, Deckers, and More
(Barrons.com) |
01:55PM
|
June PCE inflation print, auto earnings: Morning Brief
(Yahoo Finance Video) |
01:26PM
|
Stocks jump on cool inflation data, 3M pops on earnings: Yahoo Finance
(Yahoo Finance Video) |
01:14PM
|
Top Stock Movers Now: 3M, Charter Communications, Dexcom, and More
(Investopedia) |
|
DexCom, Inc. is a medical device company, which engages in the design, development, and commercialization of glucose monitoring systems for ambulatory use by people with diabetes. Its products include Dexcom G6, Dexcom G7, Dexcom Stelo, Dexcom Share, Dexcom Real-Time API, and Dexcom ONE. The company was founded by John F. Burd on May 13, 1999 and is headquartered in San Diego, CA. |
Insider Trading |
Relationship |
Date |
Transaction |
Cost |
#Shares |
Value ($) |
#Shares Total |
SEC Form 4 |
Brown Michael Jon | EVP Chief Legal Officer | Jun 28 '24 | Sale | 114.29 | 659 | 75,317 | 66,901 | Jun 28 05:34 PM | FOLETTA MARK G | Director | Jun 18 '24 | Sale | 116.79 | 3,306 | 386,122 | 56,398 | Jun 20 04:50 PM | FOLETTA MARK G | Director | Jun 17 '24 | Sale | 117.26 | 2,694 | 315,907 | 59,704 | Jun 20 04:50 PM | Heller Bridgette P | Director | Jun 14 '24 | Sale | 113.55 | 1,000 | 113,550 | 25,349 | Jun 18 07:16 PM | Leach Jacob Steven | EVP Chief Operating Officer | Jun 10 '24 | Sale | 115.05 | 745 | 85,713 | 265,577 | Jun 11 06:38 PM |
|
|
![](gfx/nic2x2.gif) |
![PSIG - PS International Group Ltd. - Stock Price Chart](https://charts2-node.finviz.com/chart.ashx?cs=l&t=PSIG&tf=d&s=linear&ct=candle_stick&tm=d&o[0][ot]=sma&o[0][op]=50&o[0][oc]=FF8F33C6&o[1][ot]=sma&o[1][op]=200&o[1][oc]=DCB3326D&o[2][ot]=sma&o[2][op]=20&o[2][oc]=DC32B363&o[3][ot]=patterns&o[3][op]=&o[3][oc]=000) |
Market Cap | 5.13M | EPS (ttm) | -0.31 |
P/E | - | EPS this Y | - |
Forward P/E | - | EPS next Y | - |
PEG | - | EPS past 5Y | - |
P/S | - | EPS next 5Y | - |
P/B | 0.88 | EPS Q/Q | -4508.33% |
Dividend | - | Sales Q/Q | - |
Insider Own | 76.39% | Inst Own | 22.34% |
Insider Trans | 0.00% | Inst Trans | - |
Short Float | - | Earnings | - |
Analyst Recom | - | Target Price | - |
Avg Volume | 193.44K | 52W Range | 1.55 - 12.25 |
|
|
PS International Group Ltd. engages in providing logistics and supply chain solutions. The company was founded on September 12, 2023 and is headquartered in Hong Kong. |
|
| ![](gfx/nic2x2.gif) |
![POAI - Predictive Oncology Inc - Stock Price Chart](https://charts2-node.finviz.com/chart.ashx?cs=l&t=POAI&tf=d&s=linear&ct=candle_stick&tm=d&o[0][ot]=sma&o[0][op]=50&o[0][oc]=FF8F33C6&o[1][ot]=sma&o[1][op]=200&o[1][oc]=DCB3326D&o[2][ot]=sma&o[2][op]=20&o[2][oc]=DC32B363&o[3][ot]=patterns&o[3][op]=&o[3][oc]=000) |
Market Cap | 5.66M | EPS (ttm) | -3.66 |
P/E | - | EPS this Y | - |
Forward P/E | - | EPS next Y | - |
PEG | - | EPS past 5Y | 53.33% |
P/S | 2.89 | EPS next 5Y | - |
P/B | 1.38 | EPS Q/Q | -20.41% |
Dividend | - | Sales Q/Q | 74.93% |
Insider Own | 3.69% | Inst Own | 5.55% |
Insider Trans | 0.00% | Inst Trans | -16.14% |
Short Float | 0.48% | Earnings | May 15/b |
Analyst Recom | 1.00 | Target Price | 100.00 |
Avg Volume | 4.42M | 52W Range | 0.89 - 5.94 |
|
|
|
Predictive Oncology, Inc. engages in the application of artificial intelligence medicine business and provision of cleared STREAMWAY System for automated, direct-to-drain medical fluid disposal, and associated products. It operates through the following segments: Helomics, zPREDICTA, Skyline, Soluble, and Corporate. The Helomics segment includes contract services that include the application of AI, partnering projects, and clinical testing. The zPREDICTA segment specializes in organ-specific disease models that provide 3D reconstruction of human tissues accurately representing each disease state and mimicking drug response enabling accurate testing of anticancer agents. The Skyline segment is composed of the STREAMWAY System product sales, and its TumorGenesis subsidiary is included within the Corporate segment. The Soluble segment provides services using an automated system that conducts self-interaction chromatography screens, using additives and excipients commonly included in protein formulations resulting in soluble and physically stable formulations for biologics. The company was founded by Lawrence W. Gadbaw, Peter L. Morawetz, and Jeffrey K. Drogue on April 23, 2002 and is headquartered in Pittsburgh, PA. |
Insider Trading |
Relationship |
Date |
Transaction |
Cost |
#Shares |
Value ($) |
#Shares Total |
SEC Form 4 |
Nuzum Charles Lee Sr | Director | Sep 25 '23 | Sale | 3.04 | 10,000 | 30,387 | 24,033 | Sep 27 05:03 PM |
|
|
![](gfx/nic2x2.gif) |
![NXTT - Next Technology Holding Inc. - Stock Price Chart](https://charts2-node.finviz.com/chart.ashx?cs=l&t=NXTT&tf=d&s=linear&ct=candle_stick&tm=d&o[0][ot]=sma&o[0][op]=50&o[0][oc]=FF8F33C6&o[1][ot]=sma&o[1][op]=200&o[1][oc]=DCB3326D&o[2][ot]=sma&o[2][op]=20&o[2][oc]=DC32B363&o[3][ot]=patterns&o[3][op]=&o[3][oc]=000) |
Market Cap | 4.02M | EPS (ttm) | 10.63 |
P/E | 0.14 | EPS this Y | - |
Forward P/E | - | EPS next Y | - |
PEG | - | EPS past 5Y | -122.12% |
P/S | 1.53 | EPS next 5Y | - |
P/B | 0.06 | EPS Q/Q | 1070.06% |
Dividend | - | Sales Q/Q | -100.00% |
Insider Own | 46.06% | Inst Own | 1.25% |
Insider Trans | 0.00% | Inst Trans | - |
Short Float | 0.31% | Earnings | - |
Analyst Recom | - | Target Price | - |
Avg Volume | 62.88K | 52W Range | 1.83 - 14.34 |
|
|
|
Next Technology Holding, Inc. engages in the provision of software development services to the customers and bitcoin acquisition. The company was founded on March 28, 2019 and is headquartered in Shenzhen, China. |
|
| ![](gfx/nic2x2.gif) |
![PMN - ProMIS Neurosciences Inc. - Stock Price Chart](https://charts2-node.finviz.com/chart.ashx?cs=l&t=PMN&tf=d&s=linear&ct=candle_stick&tm=d&o[0][ot]=sma&o[0][op]=50&o[0][oc]=FF8F33C6&o[1][ot]=sma&o[1][op]=200&o[1][oc]=DCB3326D&o[2][ot]=sma&o[2][op]=20&o[2][oc]=DC32B363&o[3][ot]=patterns&o[3][op]=&o[3][oc]=000) |
Market Cap | 30.34M | EPS (ttm) | -0.84 |
P/E | - | EPS this Y | 58.88% |
Forward P/E | 2.28 | EPS next Y | 259.75% |
PEG | - | EPS past 5Y | 11.39% |
P/S | - | EPS next 5Y | - |
P/B | 393.12 | EPS Q/Q | 67.81% |
Dividend | - | Sales Q/Q | - |
Insider Own | 24.11% | Inst Own | 12.30% |
Insider Trans | 0.00% | Inst Trans | - |
Short Float | 0.18% | Earnings | May 14/a |
Analyst Recom | 1.00 | Target Price | 8.75 |
Avg Volume | 7.37K | 52W Range | 0.95 - 3.82 |
|
|
|
ProMIS Neurosciences, Inc. engages in the discovery and development of precision medicine solutions for early detection and effective treatment of neurodegenerative diseases. It focuses on the progression of Alzheimer's disease, amyotrophic lateral sclerosis, and Parkinson's disease. The company was founded by Neil Cashman and Vigen Nazarian on January 23, 2004 and is headquartered in Toronto, Canada. |
|
![](gfx/nic2x2.gif) |
![ABVE - Above Food Ingredients Inc. - Stock Price Chart](https://charts2-node.finviz.com/chart.ashx?cs=l&t=ABVE&tf=d&s=linear&ct=candle_stick&tm=d&o[0][ot]=sma&o[0][op]=50&o[0][oc]=FF8F33C6&o[1][ot]=sma&o[1][op]=200&o[1][oc]=DCB3326D&o[2][ot]=sma&o[2][op]=20&o[2][oc]=DC32B363&o[3][ot]=patterns&o[3][op]=&o[3][oc]=000) |
Market Cap | 11.68M | EPS (ttm) | -0.02 |
P/E | - | EPS this Y | - |
Forward P/E | - | EPS next Y | - |
PEG | - | EPS past 5Y | - |
P/S | - | EPS next 5Y | - |
P/B | 0.55 | EPS Q/Q | 96.65% |
Dividend | - | Sales Q/Q | - |
Insider Own | 36.29% | Inst Own | 18.13% |
Insider Trans | 0.00% | Inst Trans | 5.14% |
Short Float | 2.86% | Earnings | - |
Analyst Recom | - | Target Price | - |
Avg Volume | 103.28K | 52W Range | 1.55 - 13.50 |
|
|
|
Above Food Ingredients, Inc. engages in operating its subsidiaries, Bite Acquisition Corp. (Bite) and Above Food Corp. (Above Food). The Bite is a blank check company that affects a merger, stock exchange, asset acquisition, stock purchase, reorganization or similar business combination with one or more businesses. The Above Food is an ingredient company that provides food products and brands. The company was founded by Lionel Kambeitz on April 18, 2023 and is headquartered in Regina, Canada. |
|
| ![](gfx/nic2x2.gif) |
![SLNA - Selina Hospitality PLC. - Stock Price Chart](https://charts2-node.finviz.com/chart.ashx?cs=l&t=SLNA&tf=d&s=linear&ct=candle_stick&tm=d&o[0][ot]=sma&o[0][op]=50&o[0][oc]=FF8F33C6&o[1][ot]=sma&o[1][op]=200&o[1][oc]=DCB3326D&o[2][ot]=sma&o[2][op]=20&o[2][oc]=DC32B363&o[3][ot]=patterns&o[3][op]=&o[3][oc]=000) |
Market Cap | 3.28M | EPS (ttm) | - |
P/E | - | EPS this Y | - |
Forward P/E | - | EPS next Y | - |
PEG | - | EPS past 5Y | - |
P/S | - | EPS next 5Y | - |
P/B | - | EPS Q/Q | - |
Dividend | - | Sales Q/Q | - |
Insider Own | 40.26% | Inst Own | 22.72% |
Insider Trans | -2.17% | Inst Trans | - |
Short Float | 6.28% | Earnings | - |
Analyst Recom | 1.00 | Target Price | 2.00 |
Avg Volume | 61.86M | 52W Range | 0.02 - 1.62 |
|
|
|
Selina Hospitality Plc engages in providing accommodation and hospitality services. It operates through Mexico, South America, North America, Central America, Europe and Africa, Israel, and Asia Pacific geographical segments. The company was founded by Rafael Museri and Daniel Rudasevski in 2014 and headquartered in London, the United Kingdom. |
Insider Trading |
Relationship |
Date |
Transaction |
Cost |
#Shares |
Value ($) |
#Shares Total |
SEC Form 4 |
Saba Capital Management, L.P. | 10% Owner | Apr 23 '24 | Sale | 0.06 | 895,701 | 49,264 | 54,363,581 | Apr 29 12:26 PM | Saba Capital Management, L.P. | 10% Owner | Apr 22 '24 | Sale | 0.06 | 78,670 | 4,642 | 55,259,282 | Apr 29 12:26 PM |
|
|
![](gfx/nic2x2.gif) |
![SAIA - Saia Inc. - Stock Price Chart](https://charts2-node.finviz.com/chart.ashx?cs=l&t=SAIA&tf=d&s=linear&ct=candle_stick&tm=d&o[0][ot]=sma&o[0][op]=50&o[0][oc]=FF8F33C6&o[1][ot]=sma&o[1][op]=200&o[1][oc]=DCB3326D&o[2][ot]=sma&o[2][op]=20&o[2][oc]=DC32B363&o[3][ot]=patterns&o[3][op]=&o[3][oc]=000) |
Market Cap | 10.54B | EPS (ttm) | 13.80 |
P/E | 28.73 | EPS this Y | 14.43% |
Forward P/E | 21.49 | EPS next Y | 21.60% |
PEG | 1.50 | EPS past 5Y | 27.13% |
P/S | 3.54 | EPS next 5Y | 19.20% |
P/B | 5.20 | EPS Q/Q | 18.77% |
Dividend | - | Sales Q/Q | 14.27% |
Insider Own | 0.27% | Inst Own | 103.45% |
Insider Trans | -27.48% | Inst Trans | 1.23% |
Short Float | 7.21% | Earnings | Jul 26/b |
Analyst Recom | 2.11 | Target Price | 508.62 |
Avg Volume | 493.21K | 52W Range | 341.26 - 628.34 |
|
|
|
Saia, Inc. operates as a transportation holding company. The firm through its wholly-owned subsidiaries provides regional and interregional less-than-truckload (LTL) services through a single integrated organization. The firm also offers other value-added services, including non-asset truckload, expedited and logistics services across North America. The company was founded by Louis Saia, Sr. in 1924 and is headquartered in Johns Creek, GA. |
Insider Trading |
Relationship |
Date |
Transaction |
Cost |
#Shares |
Value ($) |
#Shares Total |
SEC Form 4 |
GAINOR JOHN P JR | Director | May 02 '24 | Buy | 407.00 | 500 | 203,500 | 900 | May 06 04:38 PM | COL DOUGLAS L | Executive VP, CFO & Secretary | Feb 13 '24 | Option Exercise | 235.94 | 1,134 | 267,553 | 7,435 | Feb 14 05:50 PM | COL DOUGLAS L | Executive VP, CFO & Secretary | Feb 13 '24 | Sale | 557.75 | 1,812 | 1,010,638 | 5,623 | Feb 14 05:50 PM | RAMU RAYMOND R | Exec. VP & Chief Customer Off. | Feb 09 '24 | Sale | 565.83 | 1,943 | 1,099,412 | 4,447 | Feb 12 04:31 PM | SUGAR PATRICK D | EVP Operations | Feb 09 '24 | Sale | 549.62 | 1,431 | 786,505 | 7,442 | Feb 12 04:34 PM |
|
|
![](gfx/nic2x2.gif) |
![WRLD - World Acceptance Corp. - Stock Price Chart](https://charts2-node.finviz.com/chart.ashx?cs=l&t=WRLD&tf=d&s=linear&ct=candle_stick&tm=d&o[0][ot]=sma&o[0][op]=50&o[0][oc]=FF8F33C6&o[1][ot]=sma&o[1][op]=200&o[1][oc]=DCB3326D&o[2][ot]=sma&o[2][op]=20&o[2][oc]=DC32B363&o[3][ot]=patterns&o[3][op]=&o[3][oc]=000) |
Market Cap | 702.94M | EPS (ttm) | 13.07 |
P/E | 9.19 | EPS this Y | 1.14% |
Forward P/E | 7.46 | EPS next Y | 20.69% |
PEG | 6.13 | EPS past 5Y | 9.94% |
P/S | 1.23 | EPS next 5Y | 1.50% |
P/B | 1.68 | EPS Q/Q | 43.45% |
Dividend | - | Sales Q/Q | -0.98% |
Insider Own | 15.54% | Inst Own | 85.86% |
Insider Trans | -0.09% | Inst Trans | 1.48% |
Short Float | 11.95% | Earnings | Jul 26/b |
Analyst Recom | 3.00 | Target Price | 133.00 |
Avg Volume | 36.73K | 52W Range | 94.57 - 160.07 |
|
|
|
World Acceptance Corp. engages in the small-loan consumer finance business. It offers short-term small instalment, medium-term larger loans, related credit insurance, ancillary products and services to individuals. The firm also offers income tax return preparation services to customers. The company also markets computer software and related services to financial services companies through its subsidiary, ParaData Financial Systems. It operates in the following segments: Small Loans, Large Loans, and Tax Advance Loans. World Acceptance was founded in 1962 and is headquartered in Greenville, SC. |
Insider Trading |
Relationship |
Date |
Transaction |
Cost |
#Shares |
Value ($) |
#Shares Total |
SEC Form 4 |
Umstetter Luke J. | See remarks | May 01 '24 | Sale | 136.46 | 450 | 61,407 | 14,738 | May 03 03:47 PM | Umstetter Luke J. | See remarks | Feb 01 '24 | Sale | 131.41 | 400 | 52,564 | 15,188 | Feb 02 01:23 PM | Calmes John L Jr | See remarks | Dec 01 '23 | Option Exercise | 86.52 | 6,500 | 562,380 | 35,165 | Dec 04 05:18 PM | Calmes John L Jr | See remarks | Dec 01 '23 | Sale | 113.68 | 6,500 | 738,933 | 28,665 | Dec 04 05:18 PM |
|
|
|